Heart failure with preserved ejection fraction is a heterogeneous syndrome ... and objective evidence of left ventricular diastolic dysfunction or raised left ventricular filling pressures.

The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

The following is a summary of “Reduced antioxidant high-density lipoprotein function in heart failure with preserved ejection ...

Patients with ejection fraction <40% were excluded ... placebo on the functional status of elderly patients with diastolic heart failure. [21] This was a smaller study that enrolled 74 patients ...

Diastolic heart failure is defined clinically when signs and symptoms of heart failure are present in the presence of preserved left ventricular systolic function (ejection fraction >45%).

AI model transforms heart failure care by precisely identifying cases and enhancing quality evaluations in clinical practice.

Use of finerenone for heart failure with preserved ejection fraction carries a hyperkalemia risk, especially in patients with kidney disease.

Many studies have reported that obesity causes heart failure (HF) pathogenesis ... are diminished in patients with HF with reduced ejection fraction, in proportion to disease severity, and ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Many studies have reported that obesity causes heart failure (HF) pathogenesis.